Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare Conference - Slideshow

Amphastar Pharmaceuticals presented at the Barclays 28th Annual Global Healthcare Conference in March 2026, sharing a corporate slide deck outlining its strategic priorities and financial outlook. The presentation focused on the company’s pipeline expansion, highlighting key drug development milestones and regulatory submissions expected in 2026–2027. Revenue growth projections were emphasized, with a focus on high-margin injectable and respiratory products driving profitability amid market demand. Operational efficiency initiatives, including manufacturing optimizations and cost controls, were detailed as critical to sustaining long-term margins. Investor updates included capital allocation plans, potential M&A opportunities, and R&D investments to bolster Amphastar’s competitive position in specialty pharmaceuticals.